Tocilizumab for Systemic Juvenile Idiopathic Arthritis Reply

被引：12
|
作者：
De Benedetti, Fabrizio [1 ]
机构：
[1] Osped Pediat Bambino Gesu, Rome, Italy
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 13期
关键词：
MACROPHAGE ACTIVATION SYNDROME; INTERLEUKIN-6;
D O I：
10.1056/NEJMc1301017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1256 / 1257
页数：2
相关论文
共 50 条
  • [31] Tocilizumab therapy in systemic juvenile idiopathic arthritis – lessons of real clinical practice
    Maria I Kaleda
    Irina Nikishina
    Svetlana Rodionovskaya
    Anna Shapovalenko
    Pediatric Rheumatology, 12 (Suppl 1)
  • [32] Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
    Ruperto, Nicolino
    Brunner, Hermine, I
    Ramanan, Athimalaipet, V
    Horneff, Gerd
    Cuttica, Ruben
    Henrickson, Michael
    Anton, Jordi
    Lucica Boteanu, Alina
    Calvo Penades, Inmaculada
    Minden, Kirsten
    Schmeling, Heinrike
    Hufnagel, Markus
    Weiss, Jennifer E.
    Pardeo, Manuela
    Nanda, Kabita
    Roth, Johannes
    Rubio-Perez, Nadina
    Hsu, Joy C.
    Wimalasundera, Sunethra
    Wells, Chris
    Bharucha, Kamal
    Douglass, Wendy
    Bao, Min
    Mallalieu, Navita L.
    Martini, Alberto
    Lovell, Daniel
    De Benedetti, Fabrizio
    RHEUMATOLOGY, 2021, 60 (10) : 4568 - 4580
  • [33] Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
    E Alexeeva
    R Denisova
    S Valieva
    T Bzarova
    K Isayeva
    T Sleptsova
    E Mitenko
    Pediatric Rheumatology, 9 (Suppl 1)
  • [34] TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. RUSSIAN EXPERIENCE
    Alekseeva, E.
    Denisova, R.
    Valieva, S.
    Bzarova, T.
    Isayeva, K.
    Sleptsova, T.
    Mitenko, E.
    Chistyakova, E.
    Fetisova, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 736 - 737
  • [35] Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
    O Nemiche
    R Dagner
    P Quartier
    R Cimaz
    O Richer
    P Pillet
    M Hofer
    Pediatric Rheumatology, 9 (Suppl 1)
  • [36] Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis
    Yasuoka, Ryuhei
    Iwata, Naomi
    Abe, Naoki
    Kohagura, Toaki
    Nakaseko, Haruna
    Shimizu, Masaki
    Kawabe, Shinji
    MODERN RHEUMATOLOGY, 2019, 29 (02) : 324 - 327
  • [37] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    Ramanan, Athimalaipet V.
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    RHEUMATOLOGY, 2019, 58
  • [38] MACROPHAGE ACTIVATION SYNDROME IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB
    De Benedetti, Fabrizio
    Schneider, Rayfel
    Weitzman, Sheila
    Devlin, Clare
    Daimaru, Kaori
    Yokota, Shumpei
    Takei, Syuji
    Ravelli, Angelo
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S5 - S5
  • [39] Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab
    Ravelli, Angelo
    Schneider, Rayfel
    Weitzman, Sheila
    Devlin, Clare
    Daimaru, Kaori
    Yokota, Shumpei
    Takei, Syuji
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S83 - S84
  • [40] Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report
    Ye Zhang
    Jinli Ru
    Jinxiu Zhang
    Rheumatology and Therapy, 2023, 10 : 293 - 300
12345